EE+ POEM Archive
Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Cholesterol-reducer Evolocumab Associated With a Nonsignificant Increase in Cardiovascular Mortality (FOURIER)." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315902/all/Cholesterol_reducer_evolocumab_associated_with_a_nonsignificant_increase_in_cardiovascular_mortality__FOURIER_.
Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315902/all/Cholesterol_reducer_evolocumab_associated_with_a_nonsignificant_increase_in_cardiovascular_mortality__FOURIER_. Accessed January 12, 2025.
Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER). (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315902/all/Cholesterol_reducer_evolocumab_associated_with_a_nonsignificant_increase_in_cardiovascular_mortality__FOURIER_
Cholesterol-reducer Evolocumab Associated With a Nonsignificant Increase in Cardiovascular Mortality (FOURIER) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 January 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315902/all/Cholesterol_reducer_evolocumab_associated_with_a_nonsignificant_increase_in_cardiovascular_mortality__FOURIER_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER)
ID - 1315902
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315902/all/Cholesterol_reducer_evolocumab_associated_with_a_nonsignificant_increase_in_cardiovascular_mortality__FOURIER_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
